InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Harold Shlevin. Director active across 1 company, notably GALECTIN THERAPEUTICS INCORPORATED. Cumulatively, 2 filings have been published. Activity tracked since 26 June 2026. The latest transaction was filed on 29 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations